Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-25-076870
Filing Date
2025-04-09
Accepted
2025-04-09 16:22:47
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A d949921ddefa14a.htm DEFA14A 11766
2 GRAPHIC g949921dsp002.jpg GRAPHIC 274584
3 GRAPHIC g949921dsp003.jpg GRAPHIC 265339
4 GRAPHIC g949921g00s01.jpg GRAPHIC 63314
  Complete submission text file 0001193125-25-076870.txt   840002
Mailing Address 126 EAST LINCOLN AVENUE P.O. BOX 2000 RAHWAY NJ 07065
Business Address 126 EAST LINCOLN AVENUE P.O. BOX 2000 RAHWAY NJ 07065 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-06571 | Film No.: 25825497
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)